Results 111 to 120 of about 5,929,149 (180)

Utility of venoactive compounds in post-thrombotic syndrome: A systematic review. [PDF]

J Vasc Surg Venous Lymphat Disord
Gloviczki ML, Stoughton J, Puggioni A, Gloviczki P, Raffetto JD.   +4 more
europepmc   +1 more source

From Genomics to Precision Cardiology: A Comprehensive Review of Clinical Applications and Challenges in Cardiovascular Diseases

Clinical Cardiology, Volume 49, Issue 10, October 2026.
Genomic medicine in cardiovascular care is progressing from established diagnostic applications toward integrated risk prediction, multiomics, and emerging therapeutic strategies. ABSTRACT Background Genomic cardiology is an emerging field integrating genetic, molecular, imaging, and digital health data to improve cardiovascular disease (CVD ...
Neda Mohsen‐Pour, Shiva Esmaeili, Aydin Feyzi, Ali Sharafi, Majid Maleki, Samira Kalayinia   +5 more
wiley   +1 more source

Learning curve in the endovascular treatment of chronic post-thrombotic syndrome in a French center. [PDF]

CVIR Endovasc
Segui P, Monnin-Barès V, Nou M, Bommart S, Zarqane H, Vanoverschelde J, Vernhet-Kovacsik H.   +6 more
europepmc   +1 more source

The risk for post-thrombotic syndrome of subjects with deep vein thrombosis in an Indonesian referral hospital: a retrospective cohort study. [PDF]

Thromb J, 2023
Ariyanti F, Sukrisman L, Antono D, Harimurti K.   +3 more
europepmc   +1 more source

A single‐cell census of pulmonary endarterectomies tissue across different anatomical regions in chronic thromboembolic pulmonary hypertension

Clinical and Translational Medicine, Volume 16, Issue 10, October 2026.
This study provides the first intra‐individual, regional single‐cell comparison of main/lobar versus bifurcate pulmonary endarterectomy (PEA) specimens. It reveals distinct macrophage polarisation, divergent T‐cell compositions and pronounced smooth muscle cell (SMC)‐to‐myofibroblast transition in the bifurcate region. These findings highlight regional
Rui Zhang, Yunlong Zhang, Huiting Li, Jing Zhang, Shou Han, Xinbo Cheng, Qinhua Zhao, Jing He, Cijun Luo, Hongling Qiu, Jianfeng Zhang, Sugang Gong, Lan Wang   +12 more
wiley   +1 more source

Association of post-thrombotic syndrome with metabolic syndrome and inflammation - a systematic review. [PDF]

Front Immunol
Alturky S, Ashfaq Y, Elhance A, Barney M, Wadiwala I, Hunter AK, Nguyen KP.   +6 more
europepmc   +1 more source

A Systematic Review and Bayesian Network Meta-Analysis on the Effect of Different Anticoagulants on the Prophylaxis of Post-Thrombotic Syndrome after Deep Venous Thrombosis. [PDF]

J Clin Med, 2023
Shao J, Zhou Q, Jin F, Reissfelder C, Sigl M, Yagublu V, Keese M.   +6 more
europepmc   +1 more source

Efficacy and related factors of levonorgestrel‐releasing intrauterine system combined with metformin in fertility‐preserving treatment for atypical endometrial hyperplasia and early endometrial cancer: A retrospective cohort study

International Journal of Gynecology &Obstetrics, Volume 175, Issue 1, Page 396-407, October 2026.
Abstract Objective To compare the efficacy of the levonorgestrel‐releasing intrauterine system combined with metformin versus oral progestin combined with metformin in fertility‐preserving treatment for patients with atypical endometrial hyperplasia and early endometrial cancer, and to analyze related factors affecting efficacy.
Pengpeng Gu, Jialu Gao, Yuxin Li, Mei Huang, Xiaoshuang Wang, Xin Zhao   +5 more
wiley   +1 more source

Predictive factors for complete recovery of post-thrombotic syndrome 6 months after venous recanalization. [PDF]

J Vasc Surg Venous Lymphat Disord
Khider L, Del Giudice C, Gendron N, Gobert C, Planquette B, Al Ahmar M, Goudot G, Messas E, Sapoval M, Mirault T.   +9 more
europepmc   +1 more source

Exposure–Response Analyses of Ropeginterferon Alfa‐2b in Essential Thrombocythemia

The Journal of Clinical Pharmacology, Volume 66, Issue 10, October 2026.
Abstract Ropeginterferon alfa‐2b is a new‐generation interferon therapy for the treatment of myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET). This investigation was designed to characterize its population pharmacokinetics–pharmacodynamics (PopPK‐PD) and delineate exposure–response (E‐R) relationships in ET. A population PK
Albert Qin, Lucia Masarova, Haoqi Chen, Zhijian Xiao, Jie Jin, Harinder Gill, Brandi N Reeves, Firas El Chaer, Keita Kirito, Norio Komatsu, Ghaith Abu‐Zeinah, Kazuya Shimoda, Oleh Zagrijtschuk, Toshiaki Sato, Daoxiang Wu, Lei Wu, Xia Su, Yucheng Gao, Jie Cui, Lei Zhang, Ruben A Mesa   +20 more
wiley   +1 more source